ANNE HUANG, MBA

Morristown, NJ

adb2uw@r.postjobfree.com http://www.linkedin.com/in/Anne-Huang-MBA/ TRUSTED FINANCE LEADER / STRATEGIC BUSINESS PARTNER Deliver Revenue Growth Optimize Resource Allocation Increase Profitability High-impact customer-centric pharmaceutical executive influential with commercial leaders in developing business strategies. Recognized for genuine ‘can-do’ attitude, passion for excellence, and commitment to exceeding targets with integrity. Strengths include optimizing resource allocation as part of product lifecycle management. Adept at seamless integration through complex business transformation. Change agent and advocate for continuous process improvement. Certified Lean Six Sigma Green Belt. Champion of talent development and builder of organizational capability. Dynamic and engaging presenter. Personable and full of energy. Tri-lingual in English (fluent), Chinese

(native) and Japanese (basic).

Areas of expertise include:

Business Planning and Analysis Sales Forecast and Modeling

Budget and Strategic Planning Resources Allocation Optimization

Performance Dashboard Financial / Business System Implementation

Business Story Telling Business Process Improvement PROFESSIONAL EXPERIENCE

FERRING PHARMACEUTICALS, Parsippany, NJ 2018 - 2019 Director, Business Planning

Provide strategic decision support to CEO and Chief Commercial Officer. Lead brand planning and tactical review process with Executive Leadership Team. Drive integration and alignment between Marketing and Finance.

Orchestrated 2019 Budget and Brand Planning with large cross-functional teams, improved quality, streamlined processes and shortened review time by leveraging online system. Received CEO award for quality of 2019 Budget and rave reviews from senior executives in global headquarters.

Constructed event-based, multiple-scenario sales forecast model, rolled out across 6 business units in 1 month and trained 3 business analysts. Ensured robustness and credibility of Sales target.

Created forward-looking key performance indicators and Brand Performance Dashboard, communicated early indicators of business performance and enabled proactive decision making by C-suite. NOVARTIS PHARMACEUTICAL CORPORATION, East Hanover, NJ 2006 - 2018 Finance Business Partner, Oncology Business Unit (BU) 2018 Led Oncology BU ($6.0B Sales) strategic plan, budget, rolling forecast, risks and opportunities, and performance reporting. Delivered strategic business decision support to BU President and CFO.

Built and automated comprehensive financial performance dashboard by leveraging Business Planning and Consolidation (BPC) system. Offered C-suite real-time business update by shortening report production time.

Produced insightful business analytics for quarter Invest Relations review by partnering with franchises leads.

Developed marketing teams’ finance acumen and enabled 30 marketers to assume greater financial accountability by providing training on Profit and Loss statements, key financial concepts, and processes. ANNE HUANG adb2uw@r.postjobfree.com PAGE TWO

NOVARTIS PHARMACEUTICAL CORPORATION (Continued)

Finance Business Partner, Ophthalmology Business Unit 2016 - 2017 Served as Finance Head for Otic / Ocular Allergy Franchise ($400M Sales). Guided P&L, strategic plan, budget, and business decision support. Oversaw sales and production forecast for $1.5B portfolio (50+ brands across 4 therapeutic areas). Promoted 1 Senior Financial Analyst.

Integrated $1.5B Ophthalmology BU from Alcon division into Pharmaceutical division in record time as part of complex reorganization. Ensured seamless transition and business continuation.

Designed Finance organization structure, secured proper resources, reduced cost and heightened productivity.

Chaired set-up of sales and production forecast processes, defined roles and responsibilities of finance and marketing teams, optimized supply for LOE product while sufficiently meeting demands of patients.

Steered business through portfolio transition period by prioritizing marketing and selling resource allocation.

Generated NPV scenario analysis to support strategic business decision in product lifecycle management.

Improved Gross 2 Net (Revenue Deduction) $1.5B forecast accuracy through collaboration with Market Access and Contract team. Influenced contracting strategy through advanced pricing analytics.

Elevated engagement and career satisfaction of associates through coaching, development and promotion. Finance Business Partner, Immunology and Dermatology Business Unit 2013 - 2016 Headed Finance for Immunology Franchise ($400M Sales). In charge of P&L and business decision support. Managed 2 Senior Financial Analysts and developed 1 of them to Manager level.

Advanced Sales budget accuracy of newly launched biologics Cosenytx by triangulating demand forecast using multiple modeling methods (Patient Model, TRx Demand) and data sources (IMS, Specialty Pharmacy and Patient Hub).

Drove top line growth and achieved equity in compensation across Pharma division by setting stretch incentive goals and effective IC plan design.

Optimized resource allocations in response to product lifecycle evolution. Obtained necessary funding to support launch and promoted brands through solid business case using NPV and ROI analysis.

Conducted benchmark analysis on resourcing for new product launch and ensured adequate headcounts for the launch of new Cosentyx indication. Analysis supported resource decision by all 4 BU heads and US Pharma CFO.

Initiated audit of accounting treatment of Sample Voucher Programs across Pharma portfolio, identified inconsistency, remedied accounting journal entry for certain products and preempted compliance issue.

Revamped SOP production planning process and benefited US Pharma with simplified reporting metrics and more focused review.

Finance Manager, Field Force Commercial Analytics 2011 - 2013 Primary Care Regional Operating Units

Managed Field Incentives Budget $80M. Supervised cross-functional team of 12, including external consultants.

Performed insightful analysis of key products’ TRx (Total Prescriptions) performance using Customer Planning Tool, which critically influenced decisions on marketing and field resources allocation. Engaged key stakeholders and formed action plans to leverage growth opportunities and mitigate erosion of LOE product.

Increased utilization of Customer Planning Tool across organization by improving data quality, shortening data release time and showcasing business impact of strategic analytics and BU-focused reporting.

Strengthened Field Force commission forecast accuracy and enhanced communication and customer relationship with Sales Force Effectiveness Operations team.

Championed budget allocation process for 4 Field Force Operating Units and developed regional P&Ls for GMs. ANNE HUANG adb2uw@r.postjobfree.com PAGE THREE

NOVARTIS PHARMACEUTICAL CORPORATION (Continued)

Identified productivity opportunities for off-shoring and trained group on selected financial activities. Finance Manager, Primary Care Business Unit Headquarters 2009 - 2011 Advised proper resource allocations of $200M brand budget for Chronic Care and Mature Products business units.

Governed Enablex Alliance budget. Prepared Brand Resources Equalization and Gross Profit Split calculation. Finance Manager, Infectious Disease, Transplant and Immunology Business Unit 2007 - 2009 Administered $70M Marketing and Selling budget through partnership with cross-functional teams. Finance Manager, Corporate Planning, General Medicine 2006 - 2007 Coordinated between global headquarters and US Pharma division including 6 business units on strategic plan, budget, rolling forecast, risks and opportunities, and performance reporting. Supported US Pharma division CEO and CFO on presentations to Board of Directors and Investor Relations review. UNILEVER, Greenwich, CT 2004 - 2006

Associate Finance Manager, Business Decision Support, Home and Personal Care Global Finance Lead on Dove brand. Led the BP&A in regions and developed global pro-forma P&Ls and Capital Expenditure Proposals for product launches through Integrated Business Process and using @Risk simulation model. EDUCATION

Master of Business Administration (MBA), Finance, Kelly School of Business, Indiana University, Bloomington, IN Graduate, Indiana University Entrepreneur Academy

Master of Business Administration (Mini MBA), Strategic Supply Chain, Lean Six Sigma, Rutgers Business School, Rutgers University, New Brunswick, NJ

Certified Lean Six Sigma Green Belt Executive

Bachelor of Arts (BA), International Finance, East China Normal University, Shanghai, P.R. China AWARDS

Ferring Pharmaceuticals US CEO Award for 2019 Budget (2018) Novartis Pharma Global CFO Business Excellence Award for Cosentyx Biologics Blockbuster Launch (2015) Novartis Pharma US Business Excellence Award for Forecasting Business Scenarios for Portfolio Changes (2007) Novartis Pharma US Business Excellence Award for Automating “Financial Consolidation Reporting System” (2006) 33 Novartis Bravo Awards Internal award to recognize excellence by customers, peers, managers (2009 - 2018) Unilever US CFO Value into Action Award for Reducing Cost of Goods Sold across portfolio (2006) Unilever US CFO Value into Action Award for Decision Modeling under Uncertainty (2005) FINANCIAL APPLICATIONS

SAP ERP Cognos BI TM1 BPC Hyperion Essbase IntegriChain @Risk Simulation Modeling

Contact this candidate